Bombay Enterprises

Soluble Insulin Injection I P Human Actrapid (typically 40 IU/ml or 100 IU/ml) is a short-acting human insulin. It is used to manage blood sugar levels for people with type 1 and type 2 diabetes. The injection is usually given under the skin in the abdomen, thigh, or upper arm, 15 to 30 minutes before meals. 

Insuman Rapid Injection is a short-acting human insulin used to treat type 1 and type 2 diabetes mellitus in adults and children (over two years) by controlling blood sugar levels, especially after meals. It helps transport glucose into cells for energy and reduces liver sugar production, preventing diabetes-related complications. 

The HumaPen Ergo II is a reusable 3 mL insulin pen designed by Eli Lilly for subcutaneous injection of insulin, allowing for precise dosing from 1 to 60 units in 0.5-unit increments. To use, insert a compatible cartridge, prime with 2 units to remove air bubbles, dial the prescribed dose, and inject at a 90-degree angle, holding for 10 seconds. 

Saxenda (liraglutide) is an injectable medication used for weight management in certain individuals. It is administered as a daily injection under the skin. 

Saxenda (liraglutide) 3 mg injection is a prescription, once-daily subcutaneous medication for chronic weight management in adults (BMI $\ge$30 or $\ge$27 with co-morbidities) and adolescents (12-17), used alongside a reduced-calorie diet and increased physical activity. It acts as a GLP-1 receptor agonist to decrease appetite. 

NovoMix 30 FlexPen (biphasic insulin aspart) is a pre-mixed, fast-acting insulin for managing type 1 and type 2 diabetes in adults and children (10+ years). It combines 

NovoRapid 100IU/ml FlexPen is used for blood sugar control in people with type 1 and type 2 diabetes mellitus. It is a fast-acting type of insulin that helps to lower blood sugar levels after meals and reduce the chances of developing serious complications of diabetes.

Insulin Glargine 100U/ml is a long-acting basal insulin used once daily, at the same time every day, to treat type 1 and type 2 diabetes by controlling blood sugar for 24 hours. It is injected subcutaneously (under the skin) into the abdomen, thigh, or upper arm. Key safety measures include rotating injection sites to prevent skin thickening, not mixing it with other insulins, and checking for hypoglycemia. 

Tresiba FlexTouch is a once-daily, long-acting basal insulin pen used to treat types 1 and 2 diabetes. Users must prime the pen with 2 units, select the prescribed dose (up to 160 units), inject subcutaneously into the abdomen, thigh, or upper arm, and hold for 6 seconds. It works for 24+ hours and is stable at room temperature for 56 days.